Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001005794-06-000344

Chief Financial Officer acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CULPEPPER PETER R · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2006-07-30 Exercise or conversion : show line 1 in the form +3,500 $1.10 $3,850 51,581 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2006-07-30 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −3,500 $1.10 2014-02-25 3,500 248,419 D
Loading xslF345X02/primary_doc.xml…